Cidara Therapeutics (CDTX) Reports Q4 Loss of $0.88/Share

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($0.88), versus ($0.72) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits